Table 2 Planned titration regime of IMP during ILiAD study
Daily morning dose (each tablet 250 mg) | Daily evening dose (each tablet 250 mg) | |
|---|---|---|
Week 1 | Nil | One tablet |
Week 2 | One tablet | One tablet |
Week 3 | One tablet | Two tablets |
Week 4 | Two tablets | Two tablets |
Week 5 | Two tablets | Two tablets |
Week 6 | Two tablets | Two tablets |
Week 7 | Two tablets | Two tablets |
Week 8 | Two tablets | Two tablets |
Week 9 | One tablet | Two tablets |
Week 10 | One tablet | One tablet |
Week 11 | Nil | One tablet |
Week 12 | Nil | Nil |